Loading...
XHKG
1066
Market cap3.18bUSD
Dec 05, Last price  
5.52HKD
1D
-1.25%
1Q
-2.82%
Jan 2017
6.56%
IPO
3,054.29%
Name

Shandong Weigao Group Medical Polymer Co

Chart & Performance

D1W1MN
XHKG:1066 chart
P/E
10.87
P/S
1.72
EPS
0.46
Div Yield, %
3.72%
Shrs. gr., 5y
0.29%
Rev. gr., 5y
4.78%
Revenues
13.09b
-1.08%
569,987,000786,926,0001,095,109,0001,514,367,0001,878,495,0002,462,557,0003,180,577,0003,689,115,0004,613,310,0005,277,827,0005,918,930,0006,730,340,0006,292,641,0008,808,861,00010,364,081,00011,345,252,00013,151,719,00013,619,007,00013,229,453,00013,087,071,000
Net income
2.07b
+3.24%
102,578,000182,603,000329,342,000482,394,000633,864,000799,072,0003,462,172,000996,486,000387,984,0001,084,948,0001,112,736,0001,105,933,0001,303,162,0001,472,935,0001,844,883,0002,086,783,0002,275,929,0002,764,093,0002,001,906,0002,066,668,000
CFO
2.79b
-0.31%
118,032,000176,547,000276,211,000437,482,000479,074,000523,511,000620,792,000806,031,000720,174,000711,219,0001,052,770,0001,053,139,0001,267,008,0002,219,196,0002,320,990,0002,696,608,0003,035,163,0002,214,574,0002,798,529,0002,789,971,000
Dividend
Jun 02, 20250.13222 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
IPO date
Feb 27, 2004
Employees
12,333
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT